Orion Oyj ORNBV

HEL: ORNBV | ISIN: FI0009014377 10/09/2026

79,00 EUR (-0,25%)

(-0,25%) 10/09/2026

Grafiek Orion Oyj

Grafiek Orion Oyj

1 dag1d -0,25%
1 week1w -1,19%
1 maand1m 1,22%
3 maanden3m 18,18%
6 maanden6m 11,90%
1 jaar1j 19,61%
5 jaar5j 129,92%

Orion Oyj in het nieuws

Toon enkel gratis nieuws

11 september 2026 · Orion Corporation: Acquisition of own shares during week 37, 2026 · Persbericht

4 september 2026 · Orion Corporation: Acquisition of own shares during week 36, 2026 · Persbericht

4 september 2026 · 102,000 Orion Corporation A shares converted into B shares · Persbericht

27 augustus 2026 · Orion Corporation to commence acquisition of own shares for its share-based incentive plans · Persbericht

10 augustus 2026 · Orion’s license partner Tenax Therapeutics’ Phase 3 LEVEL trial of oral levosimendan in pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF) did not reach its primary endpoint · Persbericht

17 juli 2026 · Orion Group Half-Year Financial Report January–June 2026 · Persbericht

17 juli 2026 · Orion Corporation’s financial reporting and Annual General Meeting in 2027 · Persbericht

15 juli 2026 · 45,611 Orion Corporation A shares converted into B shares · Persbericht

3 juli 2026 · Orion publishes Half-Year Report for January–June 2026 and holds a webcast on 17 July 2026 · Persbericht

30 juni 2026 · Orion Pharma announces agreement with Shilpa Medicare for nivolumab biosimilar for European market · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe